Showing results (391-400 of 430) with videos related to

Sort By:
Pageof 43
Neuro-Oncology|December 14, 2019
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomasRomain Appay, Caroline Dehais, Claude-Alain Maurage, et al.
Therapie|December 15, 2010
[Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?]Luc Buée, David Blum, Stéphanie Bombois, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2023
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trialEmilie Le Rhun, Thierry Gorlia, Jörg Felsberg, et al.
Acta Neuropathologica Communications|January 16, 2023
Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusionAlice Métais, Arnault Tauziède-Espariat, Jeremy Garcia, et al.
The American Journal of Surgical Pathology|April 2, 2015
Distinctive Patterns of Transthyretin Amyloid in Salivary Tissue: A Clinicopathologic Study of 92 Patients With Amyloid-containing Minor Salivary Gland BiopsiesMarie-Pierre Jamet, Viviane Gnemmi, Éric Hachulla, et al.
British Journal of Haematology|August 28, 2014
MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndromeStéphanie Poulain, Eileen M Boyle, Christophe Roumier, et al.
Acta Neuropathologica|January 6, 2024
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytomaMichael Weller, Jörg Felsberg, Bettina Hentschel, et al.
Virchows Archiv : an International Journal of Pathology|June 22, 2024
PIT-EASY survey: validation of the European Pituitary Pathology Group proposal for reporting pituitary neuroendocrine tumorsMaria Francesca Birtolo, Anne Jouinot, Alexandre Vasiljevic, et al.
Pageof 43